ARDS Meeting Notes
The ARDS provides participants with a Meeting Notes PDF which includes most slide presentations from the meeting. The Meeting Notes are taken and assembled by talented and rising retinal stars. They attend every talk and capture the essence of the vigorous post-talk discussion, for which the ARDS is deservedly famous.
Please email ards@medconfs.com to request a copy of the Meeting Notes. Be sure to include the year(s) requested.
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
| Past ARDS Speakers “The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.” David Parke, II |
|
|---|---|
| Records per page: | |
| 2017 45th Annual Meeting | |
| Gregg T. Kokame, MD, MMM | Update on Eylea for AMD and Retinal Vascular Disease |
| Hugo Quiroz-Mercado, MD | Reoperations in Vitreoretinal Surgery |
| Hugo Quiroz-Mercado, MD | Retinopathy of Prematurity and Associated Diseases |
| Charles C. Wykoff, MD, PhD | Outcomes with As-Needed Aflibercept in the VISTA Extension Study: ENDURANCE 1 Year Results |
| Charles C. Wykoff, MD, PhD | Peripheral Targeted Lasers WAVE and DAVE Trials |
| Panel Discussion | Advanced Management of Diabetic Macular Edema |
| Panel Discussion | Advanced Pharmacotherapy and Surgical Management for Complex Retinal Disease |
| Panel Discussion | Surgical Approaches, Advanced Viewing and Instrumention. Case Presentation. |
| 2016 44th Annual Meeting | |
| Neil M. Bressler, MD | Impact of Recent DRCR.net Randomized Clinical Trial Results on Managing Diabetic Retinopathy in 2016 |
| R.V. Paul Chan, MD | Changing the Rules in the Management of Pediatric Retina Disease |
| Donald J. D'Amico, MD | Different Preferences between US and European Vitreoretinal Surgeons |
| Donald J. D'Amico, MD | Novel Management of Enhanced S-cone Syndrome |
| Harry W. Flynn, Jr., MD | Endophthalmitis: Real World Cases for the Vitreoretinal Surgeon |
| Harry W. Flynn, Jr., MD | Management Options for VMT: What&rsquo |
| Tarek S. Hassan, MD | A Controlled Comparison of the Dexamethasone Implant vs. Intravitreal anti-VEGF Therapy for Diabetic Macular Edema |
| Tarek S. Hassan, MD | Recurrent Macular Holes in the Era of Small-Gauge Vitrectomy |
| Glenn J. Jaffe, MD | Imaging in Posterior Uveitis |
| Glenn J. Jaffe, MD | New Treatments for Intermediate, Posterior, and Panuveitis |
| Mark W. Johnson, MD | Myopic Traction Maculopathy: Mechanisms and Treatment |
| Mark W. Johnson, MD | Ocriplasmin Retinopathy: Characteristics, Mechanism, Incidence, and Reversibility |
| Szilárd Kiss, MD | Promising New Treatments for Retinal Diseases: Gene Therapy and Engineered Cells |
| Timothy G. Murray, MD, MBA | Intravitreal Pharmacotherapy in Complex Ocular Disease: Where Are We in 2016? |
| David W. Parke, II, MD | Healthcare Policy and Payment in 2020 |
| Giovanni Staurenghi, MD | Macular Atrophy in Anti-VEGF Treatment |
| Giovanni Staurenghi, MD | OCT Angiography |
| PREV | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 | NEXT |
